tgba01ad tgba01ad tgba01ad (also known as fkb01md) is a serotonin reuptake inhibitor, 5-ht1a and 5-ht1d receptor agonist, and 5-ht2 receptor antagonist which is under development by fabre-kramer for the treatment of major depressive disorder. it has been in phase ii clinical trials since 2009, and as of january 2016, remains in this phase of development. tgba01adclinical dataother namesfkb01mdroutes ofadministrationby mouthpharmacokinetic databioavailability17%elimination half-life4 hourschemical and physical data3d model (jsmol)interactive image smiles occ1oc(c(o)c1o)c2(o)nc=cc(=o)n2 inchi inchi=1s/c9h14n2o6/c12-3-4-6(14)7(15)8(17-4)9(16)10-2-1-5(13)11-9/h1-2,4,6-8,10,12,14-16h,3h2,(h,11,13)key:qjtqvqqhnghiky-uhfffaoysa-n